- Citations, last 5 years
- 680
- Works, last 5 years
- 184
- h-index
- 83
- Scientists listed
- 13
- Grants since 2016
- 1 402
Grants received
2018–2023 · research · R25
Postdoctoral Pathways: Broadening Access to Career Advancement
Bennett B Goldberg · Charles River Associates · funded by National Institutes of Health
2018–2028 · research · R35
Structure and Function of Immune Gene Regulatory Networks
Juan Ignacio Fuxman Bass · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R24
Establishing an fNIRS Ecosystem for Open Software-Hardware Dissemination
David A Boas · Charles River Associates · funded by National Institutes of Health
2018–2028 · research · R35
Structure and Function of Immune Gene Regulatory Networks
Juan Ignacio Fuxman Bass · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R21
Metamaterial-Enabled magnetic Resonance Imaging Enhancement
Stephan William Anderson · Charles River Associates · funded by National Institutes of Health
2018–2022 · research · R01
Metabolic Assessment of Anti-Microbial Susceptibility within One Cell Cycle
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R13
Academy of Aphasia Research and Training Symposium
Swathi Kiran · Charles River Associates · funded by National Institutes of Health
2018–2022 · research · R01
Metabolic Assessment of Anti-Microbial Susceptibility within One Cell Cycle
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Voice and Speech Sensorimotor Control in Parkinsons Disease
Frank H Guenther · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R61
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
Christine Cheng · Charles River Associates · funded by National Institutes of Health
2018 · research · R01
Language Processing and Word Learning in Preschoolers with Autism Spectrum Disorder
Sudha Arunachalam · Charles River Associates · funded by National Institutes of Health
2018–2019 · fellowship · F31
Neuronal Network Analysis Tools for Large Calcium Imaging Datasets
Kyle Rollins Hansen · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R01
Voice and Speech Sensorimotor Control in Parkinsons Disease
Frank H Guenther · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Role of apoE-apoER2 interactions in CNS neurons
Uwe Beffert · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Cortical Interactions Underlying Sensory Representations
Jerry L Chen · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Cortical Interactions Underlying Sensory Representations
Jerry L Chen · Charles River Associates · funded by National Institutes of Health
2018–2028 · research · R13
Academy of Aphasia Research and Training Symposium
Swathi Kiran · Charles River Associates · funded by National Institutes of Health
2018–2021 · fellowship · F32
Development of Episodic Future Thinking: Limits, Flexibility, and Neural Correlates
Tashauna Blankenship · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Role of apoE-apoER2 interactions in CNS neurons
Uwe Beffert · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Unveiling the mechanisms of ultrasound neuromodulation via spatially confined stimulation and temporally resolved recording
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2020 · research · R21
Development of label-free computational flow cytometry for high-throughput micro-organism classification
Jerome Mertz · Charles River Associates · funded by National Institutes of Health
2018–2020 · research · R03
Movement screening and modification in individuals with femoroacetabular impingement syndrome
Cara L Lewis · Charles River Associates · funded by National Institutes of Health
2018–2020 · fellowship · F31
Callous-Unemotional Behaviors from Early Childhood to Adolescence: A Longitudunal Twin Study
Megan Elizabeth Flom · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R01
The mechanism of apo-target recognition in cytsolic iron sulfur cluster biosynthesis
Deborah L Perlstein · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R35
Structure and Function of Immune Gene Regulatory Networks
Juan Ignacio Fuxman Bass · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R01
Walking and mHealth to Increase Participation in Parkinson Disease (WHIP-PD)
Gammon M. Earhart · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R25
Flipped Biomedical Grand Rounds: Creating a Clinical Immersion Classroom
Catherine M. Klapperich · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2018–2024 · cooperative agreement · U01
A multi-scale computational model of the extracellular matrix of the lung
Bela Suki · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R35
Structure and Function of Immune Gene Regulatory Networks
Juan Ignacio Fuxman Bass · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
The mechanism of apo-target recognition in cytsolic iron sulfur cluster biosynthesis
Deborah L Perlstein · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R61
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
Christine Cheng · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R33
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
Christine Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
The impact of microvascular (dys)regulation on cerebral flow and oxygen heterogeneity
David A Boas · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
The impact of microvascular (dys)regulation on cerebral flow and oxygen heterogeneity
David A Boas · Charles River Associates · funded by National Institutes of Health
2018–2022 · cooperative agreement · UF1
Population Imaging of Action Potentials by Novel Two-Photon Microscopes and Genetically Encoded Voltage Indicators
Jerry L Chen · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R01
Unveiling the mechanisms of ultrasound neuromodulation via spatially confined stimulation and temporally resolved recording
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R01
Measuring, Modeling, and Modulating Cross-Frequency Coupling
Uri Tzvi Eden · Charles River Associates · funded by National Institutes of Health